A · Large Cap · NYSE · Healthcare · Diagnostics & Research
Free AI brief
Free to track. No card required. Usually ready in 10-15 minutes.
Price, momentum, and the numbers behind the story.
Stocksbrew score
70/100
See the full financial picture
Open the five-year record, valuation checks and Wall Street view behind these scores.
Free for 3 days, then $9/mo. Cancel anytime.
Where the analysts and the crowd stand, and what it's worth to know first.
Lowest
$155
Current price
$156.46
Median target
$175
Highest
$190
What it earns and where it earns it, what you're paying for the stock, and the risk sitting on the balance sheet.
ROIC
Strong · Excellent capital returns
16.9%
ROE
Favorable · 21.3% - strong capital efficiency
21.0%
Debt / equity
Favorable · 0.47 - strong leverage
0.56x
Current ratio
Strong · Good liquidity position
2.05x
Forward P/E
Needs attention · 13% above avg
23.81x
EV / EBITDA
Rich · Earnings can't support price
22.36x
A against the names it's actually compared to.
| Company | Mkt cap | P/E | Rev growth | Score |
|---|---|---|---|---|
| $44.11B | 30.8 | +8.6% | 70 | |
| $9.95B | 18.9 | +19.7% | 78 | |
| $33.72B | 35.3 | +15.5% | 78 | |
| $4.12B | 12.4 | +13.5% | 78 | |
| $1.09T | 39.2 | +49.6% | 77 |
Every story that touched the stock this week, newest first.